Travere Therapeutics Inc (TVTX)
6.26
+0.10
(+1.62%)
USD |
NASDAQ |
May 03, 16:00
6.255
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Net Income (Quarterly): -90.17M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -90.17M |
| September 30, 2023 | 150.74M |
| June 30, 2023 | -85.63M |
| March 31, 2023 | -86.33M |
| December 31, 2022 | -65.82M |
| September 30, 2022 | -69.66M |
| June 30, 2022 | -67.03M |
| March 31, 2022 | -75.97M |
| December 31, 2021 | -51.57M |
| September 30, 2021 | -35.64M |
| June 30, 2021 | -39.01M |
| March 31, 2021 | -53.87M |
| December 31, 2020 | -121.62M |
| September 30, 2020 | -22.55M |
| June 30, 2020 | -26.07M |
| March 31, 2020 | 0.808M |
| December 31, 2019 | -30.26M |
| September 30, 2019 | -36.49M |
| June 30, 2019 | -38.70M |
| March 31, 2019 | -40.98M |
| December 31, 2018 | -7.455M |
| September 30, 2018 | -54.52M |
| June 30, 2018 | -22.33M |
| March 31, 2018 | -18.38M |
| December 31, 2017 | -17.62M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.79M |
| June 30, 2017 | -13.23M |
| March 31, 2017 | -11.09M |
| December 31, 2016 | -8.603M |
| September 30, 2016 | -37.11M |
| June 30, 2016 | -13.40M |
| March 31, 2016 | 11.22M |
| December 31, 2015 | -2.469M |
| September 30, 2015 | 105.58M |
| June 30, 2015 | -25.53M |
| March 31, 2015 | 39.66M |
| December 31, 2014 | -29.03M |
| September 30, 2014 | -17.98M |
| June 30, 2014 | 11.80M |
| March 31, 2014 | -75.74M |
| December 31, 2013 | -13.94M |
| September 30, 2013 | -10.90M |
| June 30, 2013 | -5.048M |
| March 31, 2013 | -4.869M |
| November 30, 2012 | -0.0037M |
| August 31, 2012 | -0.0035M |
| May 31, 2012 | -0.0035M |
| February 29, 2012 | -0.0043M |
| November 30, 2011 | -0.0035M |
| August 31, 2011 | -0.0035M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-121.62M
Minimum
Dec 2020
150.74M
Maximum
Sep 2023
-44.47M
Average
-51.57M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| AtriCure Inc | -13.27M |
| Bio-Rad Laboratories Inc | 349.71M |
| Artivion Inc | -3.975M |
| Shockwave Medical Inc | 44.30M |
| Perspective Therapeutics Inc | -24.68M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 45.06M |
| Total Expenses (Quarterly) | 127.90M |
| EPS Diluted (Quarterly) | -1.18 |
| Enterprise Value | 286.79M |
| Gross Profit Margin (Quarterly) | 89.87% |
| Profit Margin (Quarterly) | -200.1% |
| Earnings Yield | -25.72% |
| Normalized Earnings Yield | -72.10 |